Abstract
At the end of Summer 2020 colleges and universities had to make difficult decisions about whether to return to in-person instruction. While opening campuses could pose a major health risk, keeping instruction online could dissuade students from enrolling. Taking an ecological approach that considers the influence of state, county, and college characteristics, this study uses mixed modeling techniques and data from 89% of two- and four-year public and four-year private US colleges to assess the factors that shaped their decision to provide mostly in-person instruction as of August 1, 2020. We consider the roles of the political and religious climate, COVID-19 infections, deaths, and mask mandates, college niche, finances, dormitory capacity, faculty resistance, online readiness, and enrollment pressures. Most notably, we find that decision-making was unrelated to cumulative COVID infection and related mortality rates. The strongest predictor of in-person instruction was the proportion of state residents who voted for Trump in the 2016 presidential election. We also find that dormitory capacity, percentage of revenue from tuition, institutional importance to the local economy, graduation rates, and per capita endowment were associated with providing in-person instruction.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
Not a clinical trial. Secondary data.
Funding Statement
Not external funding was received
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
We analyzed secondary data which are in the public domain. No IRB was required.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data are available in the public domain. See article for information on where to get specific data.
